Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 8, 2008, Pages 955-958

  Summers, M ^a   Swanton, J ^a   Fernando, K ^a   Dalton, C ^a   Miller, D H ^a   Cipolotti, L ^a   Ron, M A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; ASPARTIC ACID; DIPEPTIDE; DRUG DERIVATIVE; INOSITOL; N ACETYL 1 ASPARTYLGLUTAMIC ACID; N ACETYLASPARTIC ACID; N-ACETYL-1-ASPARTYLGLUTAMIC ACID; N-ACETYLASPARTATE;

ADOLESCENT; ADULT; ARTICLE; ATROPHY; ATTENTION; CLINICAL ASSESSMENT; COGNITIVE DEFECT; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GRAY MATTER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMAGING; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANK SUM TEST; SPATIAL MEMORY; SPECTROSCOPY; STUDENT T TEST; VERBAL MEMORY; VISUAL MEMORY; WHITE MATTER; BRAIN; BRAIN VENTRICLE; COHORT ANALYSIS; DISABILITY; METABOLISM; MIDDLE AGED; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ADULT; ASPARTIC ACID; ATROPHY; BRAIN; CEREBRAL VENTRICLES; COGNITION DISORDERS; COHORT STUDIES; DIPEPTIDES; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 48249116362     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.138685     Document Type: Article

References (24)

1. Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-64.
2. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-7.
3. Tintoré M, Rovira A, Río J, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006;67:968-72.
4. Summers MM, Fisniku LK, Anderson VM, et al. Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult Scler 2007;13:1-8.
5. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
6. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444- 52.
7. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986;292:344.
8. Wechsler OA. Wechsler Adult Intelligence Test-Revised. London: The Psychological Corporation, 1981.
9. Nelson HE. The National Adult Reading Test. Windsor: NFER-Nelson, 1982.
10. Coughlan AK, Hollows AK. The adult memory and information processing battery. Leeds: St James's University Hospital, 1985.
11. Sampson H. Pacing and performance on a serial addition task. Can J Psychol 1956;10:219-25.
12. Smith A. Symbol Digit Modalities Test (SDMT) manual (revised). Los Angeles: Western Psychological Services, 1982.
13. Sahakian BJ, Owen AM. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 1992;85:399-402.
14. Burgess PW, Shallice T. The Hayling and Brixton tests. Bury St Edmunds: Thames Valley Test Company, 1997.
15. Strauss E, Sherman EM, Spreen O. A compendium of neuropsychological tests. New York: Oxford University Press, 2006.
16. Plummer DL. DispImage: a display and analysis tool for medical images. Rev Neuroradiol 1992;5:489-95.
17. Fernando KT, McLean MA, Chard DT, et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004;127:1361-9.
18. Freeborough PA, Fox NC, Kitney Rl. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997;53:15-25.
19. Feinstein A, Kartsounis LD, Miller DH, et al. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry 1992;55:869-76.
20. Amato MP, Ponziani G, Siracusa G, et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001;58:1602-6.
21. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 2006;245:41-6.
22. Compston A. Making progress on the natural history of multiple sclerosis. Brain 2006;129:561-3.
23. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006;66:685-92.
24. Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:2342-52.